An analysis of genetic biomarkers from Genetic Engineering & Biotechnology explains the differences between predictive and prognostic characteristics and provides a perspective on the current landscape of research and development for a number of key assays.

The report, written by Enal Razvi, PhD, includes such prognostic tests as Oncotype DX 21 and Mammaprint as well as predictive tests such as HER2 and BCR-ABL.